Signup is free and no credit card is required.
HomeDYN:NASDAQ
D
Dyne Therapeutics, Inc.
$13.82USD
-4.27%-0.590.00
US
NASDAQ
Healthcare
Biotechnology
Year range
6.36 - 47.45
Market cap
$1.57B USD
Avg Volume
2.6M
P/E ratio TTM
-4.14
Dividend yield TTM
0.00%
Primary exchange
NASDAQ Global Select
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops v... Read more
CEO
Mr. John G. Cox M.B.A.
Employees
192
Website
Country
US 
IPO Date
Sep 17, 2020
Headquarters
1560 Trapelo Road, Waltham
Phone
+781 786 8230
Advanced Financial Analysis
Powerful insights without barriers. No credit card or login required.
Global Stocks, ETFs & Fund Coverage
Unlimited Monthly Prompts
Chat with Voyager: AI Chatbot
Unlimited Monthly Company Reports
5 Portfolios with Unlimited Holdings
Watchlist Functionality
30 Years of Financial Data
Analyst Estimates & Ratings
Priority Support
Free access to financial analysis tools. No credit card required.
NumbersChart Mode
Valuemetrix
Sign up
Enter your information to create your account
Already have an account?
By contining, you agree to our Terms of Service and Privacy Policy.
Key financial ratios and metrics that provide insights into a company’s valuation, solvency, efficiency, and growth.
valuation
solvency
efficiency
growth CAGR
Was this helpful?
3.1
Future Estimates
8
Ownership
Who are the major shareholders and have insiders been buying or selling?
8.1
Recent Insider Transactions
NASDAQ:DYN Recent Insider Transactions by Companies or Individuals
Was this helpful?
8.2